Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on September 8, 2025
Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting
GlobeNewswire
·
September 8, 2025
LEXINGTON, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders …
Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma Accepted for Oral Presentation at CTOS 2025
GlobeNewswire
·
September 8, 2025
Data to be presented in the Immunotherapy & Cell Therapy in Sarcoma: Emerging Frontiers session at the Connective Tissue Oncology Society (CTOS) 2025 Annual Meeting SYDNEY, AUSTRALIA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: …
Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025
GlobeNewswire
·
September 8, 2025
Company to present at session titled “Personalizing Sepsis Treatment” TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and …
Aeries Technology Caps Eight Months of Momentum with Financial Turnaround, AI-Driven GCC Innovation, and Strategic Expansion
GlobeNewswire
·
September 8, 2025
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (NASDAQ: AERT), a global leader in AI-powered business transformation and Global Capability Center (GCC) services, today recapped a strong first eight months of 2025, highlighting record …
Vaxart Announces Adjournment of Special Meeting of Stockholders
GlobeNewswire
·
September 8, 2025
Meeting adjourned to September 19, 2025 at 8:30 a.m. Pacific Time Adjournment provides stockholders with more time given changes in Board composition, additional governance change considerations and future potential disclosures Vaxart encourages all …
BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration
GlobeNewswire
·
September 8, 2025
Joint oncology conference submission planned and follow-on contract discussion underway Validates BullFrog AI’s enterprise-grade platform strategy, combining automation and human-in-the-loop oversight for scalable, trustworthy analytics GAITHERSBURG, Md., …
Genius Group appoints Saifedean Ammous as Board Advisor
GlobeNewswire
·
September 8, 2025
SINGAPORE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it has appointed Saifedean Ammous as an advisor to the …
Rezolve Ai CEO Engages Wall Street with Packed September Investor Line-Up
GlobeNewswire
·
September 8, 2025
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a leader in proprietary AI-powered commerce solutions, today announced that CEO Daniel M. Wagner will present at the HC Wainwright Global Tech Investor Conference this week, …
Nuclear Power Industry Veteran Ralph Hunter Joins Board of Directors of ASP Isotopes Inc. and Board of Managers of Quantum Leap Energy LLC
GlobeNewswire
·
September 8, 2025
WASHINGTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple …
ModelOp Announces 2025 AI Governance Leadership Summit on October 15 - The Agentic Advantage: How Enterprises Innovate Without Losing Control
GlobeNewswire
·
September 8, 2025
CHICAGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Agentic AI is unlike anything large enterprises have introduced or scaled before and preparing for it requires a fundamental shift - including new architecture, control models, and an operating culture. ModelOp, …
SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds
GlobeNewswire
·
September 8, 2025
SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced the entry into …
Alterity Therapeutics Raises A$20.0 million in Strategic Placement
GlobeNewswire
·
September 8, 2025
MELBOURNE, Australia and SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …
ElevateBio Appoints Larry Lockwood, Ph.D., as Chief Commercial Officer
GlobeNewswire
·
September 8, 2025
WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, announced the appointment of Larry Lockwood, Ph.D., as Chief Commercial Officer. Dr. …
Humanoid Global Announces Strategic Investment in RideScan, a Pioneer Advancing AI for Robotics Safety and Performance
GlobeNewswire
·
September 8, 2025
Vancouver, BC …
Xtract One Selected by Delmar School District for Enhanced Security Solutions
GlobeNewswire
·
September 8, 2025
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract One Gateway (“Gateway”) system has been selected by Delmar School District in Delmar, …
TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment
GlobeNewswire
·
September 8, 2025
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has commenced in a Phase 3 trial evaluating subcutaneous BRIUMVI (ublituximab-xiiy), the company’s anti-CD20 monoclonal antibody, in people …
Angitia Biopharmaceuticals Presents First-in-Human Data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025
GlobeNewswire
·
September 8, 2025
• Clinical data demonstrated administration of AGA2115 drove dose-dependent increases in bone mineral density • The Company and collaborators also presented data from non-human primate and mouse models WESTLAKE VILLAGE, Calif., Sept. 08, 2025 (GLOBE …
Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database
GlobeNewswire
·
September 8, 2025
5,000-participant, multi-center registry supported by iMDx’s central lab and transplant center partners New hospital-based data seeks to further differentiate pending kitted assay that measures biomarker for transplanted organ rejection (dd-cfDNA) Novel …
Bitcoin Bancorp (OTC: BULT) Retained by NASDAQ-Listed Sadot Group (NASDAQ: SDOT) to Develop Institutional Bitcoin Treasury Strategy
GlobeNewswire
·
September 8, 2025
LAS VEGAS, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Bitcoin Bancorp. (OTC: BULT) (“Bitcoin Bancorp” or the “Company”), formerly Bullet Blockchain, Inc., a leading advisor in Bitcoin treasury strategies and institutional digital asset management, today announced …
Kraig Biocraft Laboratories Appoints Kenneth Le as Managing Director of Prodigy Silk
GlobeNewswire
·
September 8, 2025
ANN ARBOR, Mich., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, is happy to announce the appointment of Mr. Kenneth Le as Managing Director of its …